Search research articles
Contact Us
Filters
Showing results (581-590 of 1,142) with videos related to
Page
of 115
Sort By:
Journal of Hepatology
|
December 20, 2005
Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study
Markus Cornberg, Johannes Hadem, Eva Herrmann, et al.
Scandinavian Journal of Gastroenterology
|
December 5, 2009
Membranous Budd-Chiari syndrome in Caucasians
Sandra Ciesek, Kinan Rifai, Matthias J Bahr, et al.
European Journal of Clinical Investigation
|
December 22, 2006
Induction of hepatitis C virus (HCV)-specific T cells by needle stick injury in the absence of HCV-viraemia
A Kubitschke, M J Bahr, N Aslan, et al.
Plos One
|
April 5, 2013
NIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLD
Münevver Demir, Sonja Lang, Martin Schlattjan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 30, 2026
Resolved HBV Infection Is Not Associated With Liver-Related Outcomes in Survival Analysis of Caucasians After HCV Cure
Laura Muana Wilhelm, Albrecht Stoehr, Peter Buggisch, et al.
Substance Abuse : Research and Treatment
|
April 5, 2019
Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy-Data From the German Hepatitis C-Registry (DHC-R)
Stefan Christensen, Peter Buggisch, Stefan Mauss, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 22, 2025
Limitations of Guideline-Recommended Risk Stratification in Identifying MASLD Patients for Novel Drug Treatments
Martin Franck, Katharina John, Monika Rau, et al.
Hepatology (Baltimore, Md.)
|
February 26, 2005
Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C
Markus Reiser, Holger Hinrichsen, Yves Benhamou, et al.
Journal of Hepatology
|
May 15, 2018
Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B
Franziska Rinker, Christine L Zimmer, Christoph Höner Zu Siederdissen, et al.
Antiviral Therapy
|
June 27, 2007
Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C
Johannes Wiegand, Markus Cornberg, Nuray Aslan, et al.
Page
of 115
Search research articles
Search
Showing results (581-590 of 1,142) with videos related to
Sort By:
Page
of 115
Journal of Hepatology
|
December 20, 2005
Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study
Markus Cornberg, Johannes Hadem, Eva Herrmann, et al.
Scandinavian Journal of Gastroenterology
|
December 5, 2009
Membranous Budd-Chiari syndrome in Caucasians
Sandra Ciesek, Kinan Rifai, Matthias J Bahr, et al.
European Journal of Clinical Investigation
|
December 22, 2006
Induction of hepatitis C virus (HCV)-specific T cells by needle stick injury in the absence of HCV-viraemia
A Kubitschke, M J Bahr, N Aslan, et al.
Plos One
|
April 5, 2013
NIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLD
Münevver Demir, Sonja Lang, Martin Schlattjan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 30, 2026
Resolved HBV Infection Is Not Associated With Liver-Related Outcomes in Survival Analysis of Caucasians After HCV Cure
Laura Muana Wilhelm, Albrecht Stoehr, Peter Buggisch, et al.
Substance Abuse : Research and Treatment
|
April 5, 2019
Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy-Data From the German Hepatitis C-Registry (DHC-R)
Stefan Christensen, Peter Buggisch, Stefan Mauss, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 22, 2025
Limitations of Guideline-Recommended Risk Stratification in Identifying MASLD Patients for Novel Drug Treatments
Martin Franck, Katharina John, Monika Rau, et al.
Hepatology (Baltimore, Md.)
|
February 26, 2005
Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C
Markus Reiser, Holger Hinrichsen, Yves Benhamou, et al.
Journal of Hepatology
|
May 15, 2018
Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B
Franziska Rinker, Christine L Zimmer, Christoph Höner Zu Siederdissen, et al.
Antiviral Therapy
|
June 27, 2007
Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C
Johannes Wiegand, Markus Cornberg, Nuray Aslan, et al.
Page
of 115